Diasorin receives FDA 510(k) clearance for its Liaison Plex® System, the new multiplexing platform of the group, together with the Liaison Plex® Respiratory Panel
Diasorin (FTSE MIB: DIA) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the company’s new LIAISON PLEX® platform as